Related Experiment Video
Updated: Mar 23, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs as novel targets and tools in cancer therapy
Mohammed L Abba1, Nitin Patil1, Jörg H Leupold1
1Department of Experimental Surgery, Medical Faculty Mannheim, and Center for Biomedicine and Medical Technology Mannheim (CBTM), Ruprecht-Karls University of Heidelberg, Ludolf-Krehl-Str. 6, 68135 Mannheim, Germany.
Abstract:
MicroRNAs (miRNAs) are currently experiencing a renewed peak of attention not only as diagnostics but also especially as highly promising novel targets or tools for clinical therapy in several different malignant diseases. Moreover, the recent discovery of competing endogenous RNAs (ceRNAs) as novel miRNA-regulators has contributed exciting insights in this regard. Therefore, this review summarizes and discusses the latest findings on (1) how miRNAs have become therapeutic targets of diverse synthetic antagonists, (2) how novel endogenous regulators of miRNAs such as ceRNAs or pseudogenes could emerge as therapeutics scavenging oncogenic miRNAs and (3) how miRNAs themselves are already, and will increasingly be, used as therapeutics. Recent advances on the importance of miRNA-target affinity and the subcellular localization of miRNAs are also discussed. The potential of these developments in different tumor entities and particular hallmarks of cancer such as metastasis, disease progression, interactions with the tumor microenvironment, or cancer stem cells are equally highlighted.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
MicroRNAs
MicroRNAs
Abnormal Proliferation
lncRNA - Long Non-coding RNAs

